Abstract: An analysis method of an automatic analyzer is provided. The automatic analyzer includes: an insertion unit into which a rack is inserted; a transport line that transports the rack; a detection unit that detects a rack identifier from a rack or an attribute from a sample container which accommodates therein a sample as an object to be examined and which is mounted on a rack; an analysis module that includes a light source and a spectrometer which measures a measurement value to analyze a sample; a rack standby unit in which a rack stands by; and, a rack recovery unit that recovers a rack. In the automatic analyzer, a rack stands by in the rack standby unit until a measurement result in the analysis module is output; and is then recovered to the rack recovery unit.

Abstract: An object of the present invention is to provide a compound having an anti-inflammatory activity or a pharmacologically acceptable salt thereof. The solution of the present invention is a compound of general formula (1) or a pharmacologically acceptable salt thereof. wherein the symbols in the formula are defined below: R1: e.g., a C1-C6 alkyl group; R2: a C1-C6 alkyl group; A: e.g., an oxygen atom; and R3: e.g., a C1-C6 alkyl group.

Abstract: Provided is an automatic analyzer that can perform a reagent preparation/disposal operation comfortably and smoothly as when printing a reagent list such as a reagent preparation/disposal list on paper even without printing the reagent list. The automatic analyzer that performs analysis using a sample and a reagent, the automatic analyzer including: a storage unit that stores reagent information related to a reagent remaining amount or a reagent expiration date of each of reagent containers; and a display unit that displays a reagent list in which reminder information that gives a reminder to an operator is assigned to each of setting positions of the reagent containers based on the reagent information stored in the storage unit. The reagent managing unit updates display of the reagent list such that a reagent container selected by the operator is visually identifiable while the reagent list is displayed.

Abstract: An operator can perform exchange work of a reagent container without including a mechanism for reagent exchange and interrupting an analysis operation. An automatic analyzer includes: an analysis unit including a plurality of operation units for performing analysis of a specimen; and a control unit for controlling the analysis unit. The control unit allows the analysis unit to set to at least (a) an analysis operation mode in which a first and a second operation unit are operated for the analysis of the specimen, (b) a partial operation mode in which only the first operation unit is continuously operated after the analysis of the specimen is completed in the analysis operation mode, and (c) a reagent exchange mode in which consumables containing a reagent are exchangeable in the analysis unit. The control unit allows the analysis unit to shift from the partial operation mode to the reagent exchange mode.

Abstract: An optical fiber support structure includes: a first portion configured to support an optical fiber including a core wire and a covering surrounding the core wire, the core wire including a core and a cladding; a second portion attached to the first portion; and a relaxing portion that is connected to an end portion of the core wire and that is positioned between the first portion and the second portion, the relaxing portion having a light receiving surface configured to receive light input from a space, an area of the light receiving surface being larger than an area of the end portion of the core wire.

Abstract: An object of the present invention is to provide a compound having an anti-inflammatory activity or a pharmacologically acceptable salt thereof. The solution of the present invention is a compound of general formula (1) or a pharmacologically acceptable salt thereof. wherein the symbols in the formula are defined below: R1: e.g., a C1-C6 alkyl group; R2: a C1-C6 alkyl group; A: e.g., an oxygen atom; and R3: e.g., a C1-C6 alkyl group.

Abstract: A supporting member supports a peeled end portion formed at an end portion in longitudinal direction representing first direction of an optical fiber, the optical fiber including: a core wire including a core and a cladding; and a jacket configured to enclose the core wire, the jacket being removed at the peeled end portion to expose the core wire. The supporting member includes: a first member; a second member fixed to the first member; a housing portion provided between the first member and the second member, the housing portion extending along the peeled end portion and being configured to house the peeled end portion; and a processed member housed in the housing portion and provided around the peeled end portion, the processed member being configured to cause transmission or scattering of light leaking from the peeled end portion.

Abstract: An object of the present invention is to provide a compound having an anti-inflammatory activity or a pharmacologically acceptable salt thereof. The solution of the present invention is a compound of general formula (1) or a pharmacologically acceptable salt thereof. wherein the symbols in the formula are defined below: R1: e.g., a C1-C6 alkyl group; R2: a C1-C6 alkyl group; A: e.g., an oxygen atom; and R3: e.g., a C1-C6 alkyl group.

Abstract: Reducing screen shift operations performed in confirming a device status of an automated analysis device efficiently enhances inspection work. A tablet terminal is used to obtain device information indicating the device status of an automated analysis device and to create and display a status confirmation screen indicating the device status based on the obtained device information. The status confirmation screen has a first display area showing each device button corresponding to each of the automated analysis devices coupled to the tablet terminal and a second display area showing the device status of the automated analysis devices corresponding to the selected device button. Based on the device information of the automated analysis device corresponding to the selected device button, the information management unit creates a status screen indicating the device status in the automated analysis device and controls the display to show the status screen.

Abstract: Work, such as status confirmation, in a plurality of automatic analyzers is efficiently performed. In an automated analysis system, a tablet terminal 114 has a terminal information management unit 210 and a terminal display unit 208. A terminal information management unit 210 acquires device information showing the state status of a device from automatic analyzers 101a to 101d, and generates a status confirmation screen showing the device status of the automatic analyzer. A terminal display unit 208 displays the status confirmation screen. The status confirmation screen has a status information screen showing the device status of one automatic analyzer and a device switch button configured to switch the status information screen to a status information screen corresponding to another other automatic analyzer.

Abstract: An object of the present invention is to provide a compound having an anti-inflammatory activity or a pharmacologically acceptable salt thereof. The solution of the present invention is a compound of general formula (1) or a pharmacologically acceptable salt thereof. wherein the symbols in the formula are defined below: R1: e.g., a C1-C6 alkyl group; R2: a C1-C6 alkyl group; A: e.g., an oxygen atom; and R3: e.g., a C1-C6 alkyl group.

Abstract: Work, such as status confirmation, in a plurality of automatic analyzers is efficiently performed. In an automated analysis system, a tablet terminal 114 has a terminal information management unit 210 and a terminal display unit 208. A terminal information management unit 210 acquires device information showing the state status of a device from automatic analyzers 101a to 101d, and generates a status confirmation screen showing the device status of the automatic analyzer. A terminal display unit 208 displays the status confirmation screen. The status confirmation screen has a status information screen showing the device status of one automatic analyzer and a device switch button configured to switch the status information screen to a status information screen corresponding to another other automatic analyzer.

Abstract: An object of the present invention is to provide a compound having an anti-inflammatory activity or a pharmacologically acceptable salt thereof. The solution of the present invention is a compound of general formula (1) or a pharmacologically acceptable salt thereof. wherein the symbols in the formula are defined below: R1: e.g., a C1-C6 alkyl group; R2: a C1-C6 alkyl group; A: e.g., an oxygen atom; and R3: e.g., a C1-C6 alkyl group.

Abstract: An analysis method of an automatic analyzer is provided. The automatic analyzer includes: an insertion unit into which a rack is inserted; a transport line that transports the rack; a detection unit that detects a rack identifier from a rack or an attribute from a sample container which accommodates therein a sample as an object to be examined and which is mounted on a rack; an analysis module that includes a light source and a spectrometer which measures a measurement value to analyze a sample; a rack standby unit in which a rack stands by; and, a rack recovery unit that recovers a rack. In the automatic analyzer, a rack stands by in the rack standby unit until a measurement result in the analysis module is output; and is then recovered to the rack recovery unit.

Abstract: Provided is an automatic analyzer capable of switching an apparatus operation mode, such as automatic reexamination, without stopping measurement by efficiently using a rack. The automatic analyzer includes a storage unit that stores an operation mode, such as automatic reexamination, of the automatic analyzer, a detection unit that detects an operation mode switching rack inserted into an insertion unit, and a control unit that switches the operation mode stored in the storage unit on the basis of the detection of the operation mode switching rack by the detection unit. The control unit applies the switched operation mode to an examination object rack transported from the insertion unit to a transport line after the operation mode switching rack.

Abstract: An object of the present invention is to provide a compound having an anti-inflammatory activity or a pharmacologically acceptable salt thereof. The solution of the present invention is a compound of general formula (1) or a pharmacologically acceptable salt thereof. wherein the symbols in the formula are defined below: R1: e.g., a C1-C6 alkyl group; R2: a C1-C6 alkyl group; A: e.g., an oxygen atom; and R3: e.g., a C1-C6 alkyl group.

Abstract: An object of the present invention is to provide a compound having an anti-inflammatory activity or a pharmacologically acceptable salt thereof. The solution of the present invention is a compound of general formula (1) or a pharmacologically acceptable salt thereof. wherein the symbols in the formula are defined below: R1: e.g., a C1-C6 alkyl group; R2: a C1-C6 alkyl group; A: e.g., an oxygen atom; and R3: e.g., a C1-C6 alkyl group.

Abstract: An object of the present invention is to provide a compound having an anti-inflammatory activity or a pharmacologically acceptable salt thereof. The solution of the present invention is a compound of general formula (1) or a pharmacologically acceptable salt thereof. wherein the symbols in the formula are defined below: R1: e.g., a C1-C6 alkyl group; R2: a C1-C6 alkyl group; A: e.g., an oxygen atom; and R3: e.g., a C1-C6 alkyl group.

Abstract: Reducing screen shift operations performed in confirming a device status of an automated analysis device efficiently enhances inspection work. A tablet terminal is used to obtain device information indicating the device status of an automated analysis device and to create and display a status confirmation screen indicating the device status based on the obtained device information. The status confirmation screen has a first display area showing each device button corresponding to each of the automated analysis devices coupled to the tablet terminal and a second display area showing the device status of the automated analysis devices corresponding to the selected device button. Based on the device information of the automated analysis device corresponding to the selected device button, the information management unit creates a status screen indicating the device status in the automated analysis device and controls the display to show the status screen.

Abstract: An object of the present invention is to provide a compound having an anti-inflammatory activity or a pharmacologically acceptable salt thereof. The solution of the present invention is a compound of general formula (1) or a pharmacologically acceptable salt thereof. wherein the symbols in the formula are defined below: R1: e.g., a C1-C6 alkyl group; R2: a C1-C6 alkyl group; A: e.g., an oxygen atom; and R3: e.g., a C1-C6 alkyl group.